Exposure to the neurotropic parasite, Toxoplasma gondii, causes significant brain and behavioral anomalies in humans and other mammals. Understanding the cellular mechanisms of T. gondii-generated brain pathologies would aid the advancement of novel strategies to reduce disease. Complement factor C1q is part of a classic immune pathway that functions peripherally to tag and remove infectious agents and cellular debris from circulation. In the developing and adult brain, C1q modifies neuronal architecture through synapse marking and pruning. T. gondii exposure and complement activation have both been implicated in the development of complex brain disorders such as schizophrenia. Thus, it seems logical that mechanistically, the physiological pathways associated with these two factors are connected. We employed a rodent model of chronic infection to investigate the extent to which cyst presence in the brain triggers activation of cerebral C1q. Compared to uninfected mice, cortical C1q was highly expressed at both the RNA and protein levels in infected animals bearing a high cyst burden. In these mice, C1q protein localized to cytoplasm, adjacent to GFAP-labeled astrocytes, near degenerating cysts, and in punctate patterns along processes. In summary, our results demonstrated an upregulation of cerebral C1q in response to latent T. gondii infection. Our data preliminarily suggest that this complement activity may aid in the clearance of this parasite from the CNS and in so doing, have consequences for the connectivity of neighboring cells and synapses.
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Introduction
Exposure to the neurotropic parasite, Toxoplasma gondii, causes significant brain and behavioral alterations based on studies of experimental rodent models and human diseases (Flegr, 2007; Kannan and Pletnikov, 2012; Webster, 2001; Xiao et al., 2009) . The mechanisms by which T. gondii may precipitate central nervous system (CNS) effects are not clear, although proposed hypotheses include parasite alterations of host dopamine pathways, direct silencing of infected neurons by parasite products, and parasite-mediated acetylation of proteins in cortical astrocytes (Bouchut et al., 2015; Haroon et al., 2012; Prandovszky et al., 2011) . Investigations of pathways exploited by T. gondii are complicated by its complex developmental stages, progression of infection, diversity of strains and differential host susceptibilities. The T. gondii life cycle involves differentiation from a rapidly replicating tachyzoite mobile form to a relatively dormant bradyzoite form contained within cysts. The virulence of T. gondii strains varies significantly, ranging from the highly virulent (e.g. Type I) to intermediate or non-virulent phenotypes (e.g. Types II and III) (Halonen and Weiss, 2013) .
Complement C1q is an immune protein that bridges innate and adaptive immunity and functions to clear antigen-antibody immune complexes from systemic circulation (Walport, 2001) . A role for C1q in the pathogenesis of complex brain disorders is particularly intriguing as C1q helps to mediate synapse pruning during development and in adult neurodegenerative processes (Stephan et al., 2013; Stevens et al., 2007) . The complement pathway has been primarily examined in T. gondii in the context of the initial immune response directed at the invading mobile tachyzoite. In these studies, complement components were critical response factors, but were also targets of parasite-mediated evasion (Fuhrman and Joiner, 1989a,b; Sacks and Sher, 2002;  http://dx.doi.org/10.1016/j.bbi.2016.04.009 0889-1591/Ó 2016 Elsevier Inc. All rights reserved.
